[Neutrophil chemotactic activity in syphilis patients during treatment].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology; D010406:Penicillins / Q000627:therapeutic use; D010587:Phagocytosis / Q000187:drug effects; D012008:Recurrence; D013450:Sulfones / Q000627:therapeutic use; D013587:Syphilis / Q000188:drug therapy / Q000276:immunology*; D013592:Syphilis, Latent / Q000188:drug therapy / Q000276:immunology; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D010406:Penicillins; D013450:Sulfones; C023367:diucifon; D014498:Uracil; D001729:Bismuth
Khemotaksicheskaia aktivnost' neĭtrofilov u bol'nykh sifilisom v protsesse lecheniia.